Tuberculosis preventive therapy: scientific and ethical considerations for trials of ultra-short regimens
Walker TM. et al, (2025), The Lancet Infectious Diseases
Within-host modeling of primaquine-induced hemolysis in hemizygote glucose-6-phosphate dehydrogenase deficient healthy volunteers.
Watson JA. et al, (2025), Antimicrob Agents Chemother
Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV)
Jittamala P. et al, (2025), eClinicalMedicine, 80, 103036 - 103036
Advancing the chemotherapy of tuberculous meningitis: a consensus view.
Wasserman S. et al, (2025), The Lancet. Infectious diseases, 25, e47 - e58
Modeling the within-host dynamics of Plasmodium vivax hypnozoite activation: An analysis of the SPf66 vaccine trial
Mehra S. et al, (2024), Proceedings of the National Academy of Sciences, 121
Anakinra for dengue patients with hyperinflammation: protocol for a randomized double-blind placebo-controlled trial
Huyen TB. et al, (2024), Wellcome Open Research, 9, 689 - 689
Rectal artesunate: lives not saved
White NJ. et al, (2024), Transactions of The Royal Society of Tropical Medicine and Hygiene, 118, 639 - 641
Methaemoglobin as a surrogate marker of primaquine antihypnozoite activity in Plasmodium vivax malaria: A systematic review and individual patient data meta-analysis
Fadilah I. et al, (2024), PLOS Medicine, 21, e1004411 - e1004411
Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.
Schilling WHK. et al, (2024), PLoS medicine, 21
Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)
Wongnak P. et al, (2024), The Lancet Infectious Diseases, 24, 953 - 963
Lineage-informative microhaplotypes for recurrence classification and spatio-temporal surveillance of Plasmodium vivax malaria parasites
Siegel SV. et al, (2024), Nature Communications, 15
Transmission-blocking activities of artesunate, chloroquine, and methylene blue on Plasmodium vivax gametocytes.
Chaumeau V. et al, (2024), Antimicrobial agents and chemotherapy
Phase 2 pilot trial to optimise pharmacometric evaluations in Chagas disease (CHARM: CHAgas disease PharMacometrics)
Cruz CV. et al, (2024), Wellcome Open Research, 9, 342 - 342
The relationship between viral clearance rates and disease progression in early symptomatic COVID-19: a systematic review and meta-regression analysis
Singh S. et al, (2024), Journal of Antimicrobial Chemotherapy, 79, 935 - 945
Comparison of WHO versus national COVID-19 therapeutic guidelines across the world: not exactly a perfect match
Cokljat M. et al, (2024), BMJ Global Health, 9, e014188 - e014188
Spatial Analysis of Drug-Susceptible and Multidrug-Resistant Cases of Tuberculosis, Ho Chi Minh City, Vietnam, 2020-2023.
Spies R. et al, (2024), Emerging infectious diseases, 30, 499 - 509